Sandbox:Sahar: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{familytree/start |summary=PE diagnosis Algorithm.}}
 
{{familytree | | | | | | | | | | A02 | | | | | |A02=Malignant germ cell tumor}}
 
{{familytree | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | }}
 
{{familytree | | | C01 | | | | | | | | | | | | | C02 | | |C01=Prior surgery|C02=Initial surgery}}
 
{{familytree | |,|-|^|-|.| | | | | | | | | | |,|-|^|-|.| | }}
{{Family tree/start}}
{{familytree | D01 | | D02 | | | | | | | | | D03 | | D04 |D01=Complete staging|D02=Incomplete staging|D03=Fertility sparing prefered|D04=Fertility sparing not prefered}}
{{Family tree | | | | | | | | A01 | | | |A01= Patient with neck mass suspected to carotid body tumor}}
{{familytree | |!| | | |!| | | | | | | | | | |!| | | |!| | }}
{{Family tree | | | | | | | | |!| | | | | }}
{{familytree | E01 | | E02 | | | | | | | | | E03 | | E04 |E01=Treatment based<br>on<br>the staging|E02=Imaging:<br>Chest/<br>abdomen/<br>pelvis CT with contrast|E03=Fertility sparing surgery<br>and<br>complete staging|E04=Surgery to stage}}
{{Family tree | | | | | | | | B01 | | | |B01= History, Physical examination, and evaluation of cnotralateral side}}
{{familytree | | | | | |!| | | | | | | | | | |!| | | |!| | | | }}
{{Family tree | | | | | |,|-|-|^|-|-|.| | }}
{{familytree | | | | | |!| | | | | | | | | | |`| F02 |'| | | |F02=Treatment based on the staging and pathology of tumor}}
{{Family tree | | | | | C01 | | | | C02 |C01= Patients with age < 50 years<br>Patients with multiple paraganglioma<br>Patients with a positive family history| C02= The rest of the patients}}
{{familytree | | | |,|-|^|-|-|-|-|-|-|-|.| | | | | | | }}
{{Family tree | | | | | |!| | | | | }}
{{familytree | | | G01 | | | | | | | | G02 | | | | | | | | | | | | | | |G01=Yolk sac tumor<br>grade2-3 immature teratoma,<br>non-gestational choriocarcinoma<br>or mixed histology|G02=Dysgerminoma<br>or<br>grade 1 immature teratoma|L03=Dysgerminoma or grade 1 immature teratoma}}
{{Family tree | | | | | D01 | | | |D01= SDHD genetic testing}
{{familytree | | | |!| | | | | | | | | |!| | | | | | | | | | | | }}
{{Family tree | | |,|-|-|^|-|-|.| | }}
{{familytree | | | |!| | | | | |,|-|-|-|+|-|-|-|.|}}
{{Family tree | | E01 | | | | E02 |E01= Presence of SDHD mutation |E02= Absence of SDHD mutation}}
{{familytree | | | |!| | | | | I02 | | I03 | | I04 | |I02=Imaging and tumor markers<br>are<br>positive|I03=Negative imaging<br>and<br>positive tumor markers|I04=Negative imaging<br>and<br>negative or positive tumor markers}}
{{Family tree | | | | | | | | |!| | | | | }}
{{familytree | | | |!| | | | | |!| | | |!| | | |!| | | |}}
{{Family tree | | | | | | | | F01 | | | |F01= SDHC and SDHB genetic testing}
{{familytree | |,|-|^|-|.| | | K03 | | K04 | | K05 | | |K03=Decide according to fertility sparing preference<br>and/or pathologic finding<br>for surgery and<br>further adjuant therapy|K04=Observe|K05=Observe|}}
{{Family tree | | | | | |,|-|-|^|-|-|.| | }}
{{familytree | J01 | | J02 | | | | | | | | | | | | | | | | | | |J01=Imaging and tumor markers<br>are<br>positive|J02=Negative imaging<br>and<br>negative and positive tumor markers}}
{{Family tree | | | | | G01 | | | | G02 |G01= Presence of SDHC/B mutation |G02= Absence of SDHC/B mutation}}
{{familytree | |!| | | | | | | | | | | | | | | | | | | | | |}}
{{Family tree/end}}
{{familytree | K01 | | | | | | | | | | | | | | | | | | | |K01=Decide<br>according to<br>fertility sparing preference<br>for surgery and further chemotherapy|}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree/end}}

Revision as of 14:13, 8 April 2019



{{Family tree | | | | | D01 | | | |D01= SDHD genetic testing}

{{Family tree | | | | | | | | F01 | | | |F01= SDHC and SDHB genetic testing}

 
 
 
 
 
 
 
Patient with neck mass suspected to carotid body tumor
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
History, Physical examination, and evaluation of cnotralateral side
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients with age < 50 years
Patients with multiple paraganglioma
Patients with a positive family history
 
 
 
The rest of the patients
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presence of SDHD mutation
 
 
 
Absence of SDHD mutation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presence of SDHC/B mutation
 
 
 
Absence of SDHC/B mutation